Negative or weak levels of PHLPP2 immunoreactivity were observed in NSCLC tissue samples (64.9%), and PHLPP2 was clearly localized in the cytoplasmic and nuclear compartments of tumor cells (Figs 1c, 2). This evidence concerns the gene PHLPP2 and non-small cell lung carcinoma.